| ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
|---|---|---|---|---|---|---|
| CP00111 |
|
160800-65-7 |
(S)-tert-butyl 2-((1R,2R)-3-(((1S,2R)-1-hydroxy-1-phenylpropan-2-yl)amino)-1-methoxy-2-methyl-3-oxopropyl)pyrrolidine-1-carboxylate - 98% |
0 | C23H36N2O5 | |
| CP00110 |
|
159858-22-7 |
Fmoc-Val-Cit-PAB - 98% |
0 | C33H39N5O6 | |
| CP00109 |
|
799840-96-3 |
Maytansinoid DM4 - 98% |
0 | C39H56ClN3O10S | |
| CP00108 |
|
1051375-10-0 |
Cabotegravir(GSK744,GSK1265744) - 98% |
0 | C19H17F2N3O5 | |
| CP00107 |
|
147116-67-4 |
Maropitant - 98% |
0 | C32H40N2O | |
| CP00106 |
|
487-89-8 |
Indole-3-carboxaldehyde - 98% |
0 | C9H7NO | |
| CP00105 |
|
312753-53-0 |
5,6-Diethyl-2,3-dihydro-1H-inden-2-amine hydrochloride - 98%-102% |
0 | C13H20ClN | |
| CP00104 |
|
1592-23-0 |
Calcium stearate - 99% |
0 | C36H70CaO4 | |
| CP00103 |
|
3396-99-4 |
METHYL-ALPHA-D-GALACTOPYRANOSIDE - 98?02% |
0 | C7H14O6 | |
| CP00102 |
|
171752-68-4 |
(1R,3R)-9H-PYRIDO[3,4-B]INDOLE-3-CARBOXYLIC ACID, 1,2,3,4-TETRAHYDRO-1-(3,4-METHYLENEDIOXYPH ENYL), METHYL ESTER, HYDROCHLORIDE - 98%-102% |
0 | C20H19ClN2O4 | |
| CP00101 |
|
330785-81-4 |
(5-PyriMidinecarboxylicacid, 4-[[(3-chloro-4-Methoxyphenyl)Methyl]aMino]-2-(Methylthio)-,ethyl ester) - 97%-102% |
0 | C16H18ClN3O3S | |
| CP00099 |
|
— |
Enramycin Premix - 97%-102% |
0 | — | |
| CP00098 |
|
— |
Avilamycin - 98% |
0 | — | |
| CP00096 |
|
2621928-55-8 |
2-Naphthalenol - 98% |
0 | C33H31F3N6O2 | |
| CP00095 |
|
13734-36-6 |
N-T-BOC-SARCOSIN - 98% |
0 | C8H15NO4 | |
| CP00094 |
|
594-20-7 |
2,2-DICHLOROPROPANE - 98% |
0 | C3H6Cl2 | |
| CP00093 |
|
666832-71-9 |
L-Valine, 3-methyl-N-(trifluoroacetyl)- (9CI) - 98% |
0 | C19H14F2O6 | |
| CP00092 |
|
15790-07-5 |
Food Yellow 3:1 - 98% |
0 | C16H10N2O7S2.2Na | |
| CP00091 |
|
189261-10-7 |
Natalizumab-Tysabri - 98% |
0 | — | |
| CP00090 |
|
219685-50-4 |
Eculizumab - 95% |
0 | — | |
